中国组织工程研究 ›› 2020, Vol. 24 ›› Issue (14): 2243-2249.doi: 10.3969/j.issn.2095-4344.2474

• 组织构建综述 tissue construction review • 上一篇    下一篇

淫羊藿苷治疗骨性关节炎过程中对关节软骨、软骨下骨、滑膜等影响的机制

余绍涌1,刘建航2,章晓云3,徐志为1,谢桂鑫4,吴海波4,张兆剑4   

  1. 广西中医药大学附属瑞康医院,1国医大师馆,3创伤骨科与手外科,广西壮族自治区南宁市  530011;2北海市中医医院(广西中医药大学附属北海医院),广西壮族自治区北海市  536000;4广西中医药大学,广西壮族自治区南宁市  530001
  • 收稿日期:2019-07-20 修回日期:2019-07-27 接受日期:2019-09-19 出版日期:2020-05-18 发布日期:2020-03-16
  • 通讯作者: 刘建航,博士,主任医师,北海市中医医院(广西中医药大学附属北海医院),广西壮族自治区北海市 536000 并列通讯作者:章晓云,硕士,主治医师,广西中医药大学附属瑞康医院创伤骨科与手外科,广西壮族自治区南宁市 530011
  • 作者简介:余绍涌,男,1994年生,湖南省石门县人,土家族,广西中医药大学在读硕士,主要从事骨与关节退行性疾病研究。
  • 基金资助:
    国家自然科学基金(81760796);广西中青年教师基础能力提升项目(2019KY0352);广西卫生厅重点科研课题(重2012038);广西中医药大学岐黄工程培育项目(2018004)

Molecular mechanism of icariin effects on articular chondrocytes, subchondral bone and synovium in the treatment of osteoarthritis

Yu Shaoyong1, Liu Jianhang2, Zhang Xiaoyun3, Xu Zhiwei1, Xie Guixin4, Wu Haibo4, Zhang Zhaojian4   

  1. 1Chinese Medicine Clinic, 3Department of Traumatic Orthopedics and Hand Surgery, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine; 2Beihai Hospital of Chinese Medicine (Beihai Hospital Affiliated to Guangxi University of Chinese Medicine); 4Guangxi University of Chinese Medicine
  • Received:2019-07-20 Revised:2019-07-27 Accepted:2019-09-19 Online:2020-05-18 Published:2020-03-16
  • Contact: Liu Jianhang, MD, Chief physician, Beihai Hospital of Chinese Medicine (Beihai Hospital Affiliated to Guangxi University of Chinese Medicine), Beihai 536000, Guangxi Zhuang Autonomous Region, China Zhang Xiaoyun, Master, Attending physician, Department of Traumatic Orthopedics and Hand Surgery, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning 530011, Guangxi Zhuang Autonomous Region, China
  • About author:Yu Shaoyong, Master candidate, Chinese Medicine Clinic, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning 530011, Guangxi Zhuang Autonomous Region, China
  • Supported by:
    the National Natural Science Foundation of China, No. 81760796; Basic Ability Improvement Project for Young and Middle-aged Teachers in Guangxi Province, No. 2019KY0352; Key Scientific Research Project of Guangxi Provincial Health Department, No. 2012038; QiHuang Engineering Cultivation Project of Guangxi University of Chinese Medicine, No. 2018004

摘要:

文题释义:
淫羊藿苷:为淫羊藿干燥茎叶的提取物,呈淡黄色针状结晶粉末, 相对分子质量为676.65, 属黄铜类化合物,现代药理学研究发现其具有很强的生物活性, 对骨组织、免疫系统、肿瘤组织、神经系统、生殖系统、内分泌系统和心血管系统等具有显著作用。
滑膜:是关节囊的内层。滑膜呈淡红色,平滑闪光,薄而柔润,由疏松结缔组织组成,其功能是制造和调节滑液等。滑膜直接附着于关节软骨的边缘并向内贴附在关节囊内的非关节区域,覆盖在关节囊、关节内韧带、骨与肌腱表面。滑膜分泌滑液,在关节活动中起重要作用。

背景:淫羊藿苷是具有补肾强筋健骨功效的淫羊藿的主要有效成分,近年来大量的研究发现淫羊藿苷在治疗骨性关节炎方面有着显著作用。

目的:综述淫羊藿苷治疗骨性关节炎的分子机制研究进展。

方法:第一作者应用计算机以“Icariin、Osteoarthritis、Cartilage、Subchondral bone、Synovial membrane 、Synovium、Inflammation”及“淫羊藿苷、骨关节炎、骨性关节炎、软骨、软骨下骨、滑膜、炎症”作为主题词检索PubMed、中国知网、万方、维普等数据库相关文献,按入选标准及排除标准进行筛选,最终纳入42篇文献进行分析。

结果与结论:淫羊藿苷通过促进骨髓间充质干细胞的成软骨分化及增强软骨细胞和成骨细胞的增殖,抑制软骨细胞外基质的降解、降低破骨细胞的活性和减轻炎症因子所致的滑膜炎症反应来有效的治疗骨性关节炎。但其最佳有效剂量及浓度安全性仍需要大量实验研究,目前绝大部分实验仍停留在动物及组织细胞等基础实验,尚需要大量临床研究,继续完善其具体机制,以期为淫羊藿苷治疗骨关节炎提供循证医学证据。

ORCID: 0000-0002-2013-743X(余绍涌)

中国组织工程研究杂志出版内容重点:组织构建;骨细胞;软骨细胞;细胞培养;成纤维细胞;血管内皮细胞;骨质疏松组织工程

关键词: 淫羊藿苷, 骨性关节炎, 关节软骨, 软骨下骨, 滑膜, 炎症, 细胞外基质

Abstract:

BACKGROUND: Icariin is the main effective component of Epimedium, which functions to tonify the kidney, and strengthen tendons and bones. In recent years, a large number of studies have found that icariin plays a significant role in the treatment of osteoarthritis.

OBJECTIVE: To review the research progress in the molecular mechanism of icariin in the treatment of osteoarthritis.

METHODS: The first author used “Icariin, Osteoarthritis, Cartilage, Subchondral bone, Synovial membrane, synovium, Inflammation" as search words in English and Chinese to search PubMed, CNKI, WanFang, and VIP databases. According to the inclusion criteria and exclusion criteria, 42 articles were included for final analysis.

RESULTS AND CONCLUSION: Icariin can promote the cartilage differentiation of bone marrow mesenchymal stem cells and enhance the proliferation of cartilage cells and osteoblasts, to inhibit the degradation of cartilage extracellular matrix, reduce the activity of osteoclasts and alleviate synovial inflammation caused by inflammatory factors. It is an effective treatment for osteoporosis. However, the optimal effective dose and concentration safety of icariin still need a large number of experimental studies. Currently, most of the experiments are still in animal and tissue cell experiments. Numerous clinical studies are needed to continue to explore its specific mechanism in order to provide evidence-based medical evidence for icariin in the treatment of osteoarthritis.

Key words: icariin, osteoarthritis, articular cartilage, subchondral bone, synovium, inflammation, extracellular matrix

中图分类号: